Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MIF | P14174 | 8/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.37 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | NAAA | Q02083 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9957097 | 0.75 | MIF (0.55) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL8762408 | 0.69 | MIF (0.52) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL19899208 | 0.69 | SMN1; SMN2 (0.46) | SMN1; SMN2ATML3MBTL1CYP2A6EPHX1 | |
| SCHEMBL19899196 | 0.69 | SMN1; SMN2 (0.46) | SMN1; SMN2ATML3MBTL1CYP2A6EPHX1 | |
| SCHEMBL6386364 | 0.68 | MIF (0.65) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL2369596 | 0.67 | TRPA1 (0.44) | SMN1; SMN2TRPA1ATML3MBTL1EPHX1 | |
| SCHEMBL3257633 | 0.67 | SMN1; SMN2 (0.44) | SMN1; SMN2ATML3MBTL1CYP2A6EPHX1 | |
| SCHEMBL1071466 | 0.67 | TAAR1 (0.48) | SMN1; SMN2TRPA1CYP2A6EPHX1 | |
| SCHEMBL10901103 | 0.67 | SMN1; SMN2 (0.44) | SMN1; SMN2ATML3MBTL1CYP2A6EPHX1 | |
| SCHEMBL5159235 | 0.67 | EPHX1 (0.46) | SMN1; SMN2ATML3MBTL1CYP2A6EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060020299-A1 | Methods and systems for management of alzheimer's disease | BRAINSGATE LTD. (IL) | 2006-01-26 | — | — | US | claimed |
| US-20050266099-A1 | Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head | BRAINSGATE LTD. (IL) | 2005-12-01 | — | — | US | claimed |
| EP-1521614-A2 | METHODS AND SYSTEMS FOR MANAGEMENT OF ALZHEIMER'S DISEASE | Brainsgate Ltd. (IL) | 2005-04-13 | — | — | EP | claimed |
| EP-1503734-A2 | METHODS AND APPARATUS FOR MODIFYING PROPERTIES OF THE BBB AND CEREBRAL CIRCULATION BY USING THE NEUROEXCITATORY AND/OR NEUROINHIBITORY EFFECTS OF ODORANTS ON NERVES IN THE HEAD | Brainsgate Ltd. (IL) | 2005-02-09 | — | — | EP | claimed |
| WO-2003105658-A2 | METHODS AND SYSTEMS FOR MANAGEMENT OF ALZHEIMER'S DISEASE | BRAINSGATE LTD. (IL) | 2003-12-24 | — | — | WO | claimed |
| WO-2003090599-A2 | METHODS AND APPARATUS FOR MODIFYING PROPERTIES OF THE BBB AND CEREBRAL CIRCULATION BY USING THE NEUROEXCITATORY AND/OR NEUROINHIBITORY EFFECTS OF ODORANTS ON NERVES IN THE HEAD | BRAINSGATE LTD. (IL) | 2003-11-06 | — | — | WO | claimed |
| US-9233245-B2 | SPG stimulation | BRAINSGATE LTD. (IL) | 2016-01-12 | — | — | US | disclosed |
| US-20150174406-A1 | SPG STIMULATION | BRAINSGATE LTD. (IL) | 2015-06-25 | — | — | US | disclosed |
| US-8958881-B2 | Neuroprotective electrical stimulation | BRAINSGATE LTD. (IL) | 2015-02-17 | — | — | US | disclosed |
| US-8954149-B2 | External stimulation of the SPG | BRAINSGATE LTD. (IL) | 2015-02-10 | — | — | US | disclosed |
| US-20130218249-A1 | NEUROPROTECTIVE ELECTRICAL STIMULATION | BRAINSGATE LTD. (IL) | 2013-08-22 | — | — | US | disclosed |
| US-8406869-B2 | Post-acute electrical stimulation treatment of adverse cerebrovascular events | BRAINSGATE, LTD. (IL) | 2013-03-26 | — | — | US | disclosed |
| US-20120016434-A1 | POST-ACUTE ELECTRICAL STIMULATION TREATMENT OF ADVERSE CEREBROVASCULAR EVENTS | BRAINSGATE LTD. (IL) | 2012-01-19 | — | — | US | disclosed |
| WO-2004043217-A2 | STIMULATION FOR TREATING EYE PATHOLOGIES | BRAINSGATE LTD. (IL) | 2004-05-27 | — | — | WO | disclosed |
| WO-2004045242-A2 | STIMULATION FOR TREATING EAR PATHOLOGIES | BRAINSGATE LTD. (IL) | 2004-05-27 | — | — | WO | disclosed |
| WO-2004010923-A2 | DELIVERING COMPOUNDS TO THE BRAIN BY MODIFYING PROPERTIES OF THE BBB AND CEREBRAL CIRCULATION | BRAINSGATE LTD. (IL) | 2004-02-05 | — | — | WO | disclosed |
| WO-2003105658-A2 | METHODS AND SYSTEMS FOR MANAGEMENT OF ALZHEIMER'S DISEASE | BRAINSGATE LTD. (IL) | 2003-12-24 | — | — | WO | disclosed |
| WO-2003090599-A2 | METHODS AND APPARATUS FOR MODIFYING PROPERTIES OF THE BBB AND CEREBRAL CIRCULATION BY USING THE NEUROEXCITATORY AND/OR NEUROINHIBITORY EFFECTS OF ODORANTS ON NERVES IN THE HEAD | BRAINSGATE LTD. (IL) | 2003-11-06 | — | — | WO | disclosed |
| US-20030176898-A1 | Stimulation for treating eye pathologies | BRAINSGATE LTD. (IL) | 2003-09-18 | — | — | US | disclosed |
| US-20030176892-A1 | Administration of anti-inflammatory drugs into the central nervous system | BRAINSGATE, LTD. (IL) | 2003-09-18 | — | — | US | disclosed |